Clinical trial

Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.

NCT05019300

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-05-24

PhaseN/A

Study timeline

Study start (actual)2021-05-24Date precision: day

Registry last updated2021-08-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Covid19unresolved

Neurocognitive Dysfunctionunresolved

Interventions

Exposure: COVID-19 severityBIOLOGICAL

Sponsors & collaborators

Pontificia Universidad Catolica de Chilelead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

SantiagoChile1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05019300 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.